Kellerhals Carrard acts as lead Swiss legal and tax counsel to Ameliora Wealth Management in the acquisition of the Swiss offshore business of UBP Investment Advisors with American private clients. With this transaction, UBP, the
Alexander Zinser will begin as Executive Search Consultant and Partner at Roy C. Hitchman in Zurich on July 2022. The company focuses on the systematic direct search for managers and specialists on an exclusive mandate basis.
MLL Legal has acted as Swiss counsel to the financial investor Capiton on the acquisition of a majority stake in the Asyril Group, a market and technology leader in flexible parts feeding systems. Capiton has
Bär & Karrer has provided legal advice to the shareholder of Home Service who has sold its shares to Investis Holding. Home Service is a Swiss-based company active in the building services sector mainly
Baker McKenzie has advised the two owners of ARGO-HYTOS Group, Christian Kienzle and FSP CAPCELLENCE, on selling their 79.5% of the shares in the company to Voith Group, a German industrial technology group. Through this deal,
Schellenberg Wittmer advised Credaris on its purchase of credit intermediary Milenia. Both companies are Switzerland’s two leading credit intermediaries, and with this purchase agreement, Credaris will acquire 100% of the shares in Milenia. The Lausanne-based
Nexenic, the foodtech start-up, has just closed its oversubscribed financing round of CHF 1.8 Million to start and accelerate the serial production and market entry of their portable mini-steamer Steasy®. The Swiss company has developed a
+ND Capital has exited Dutch cell therapy company CellPoint by sale to the Belgian biotech company Galapagos which has acquired CellPoint for $131 million upfront and up to $105 million in milestone payments. As sole venture investor
VISCHER has advised Macquarie Bank on Swiss law issues in connection with a new USD 40 million credit facility for Trident Royalties, the London-based mining royalty and streaming company. Mayer Brown was the bank’s international
Eurocine Vaccines and Redbiotec have signed a research and collaboration agreement for the development of vaccine candidates against herpes simplex virus type 2. Under the terms of the agreement, Eurocine will have exclusive international rights to
